๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Coronary Artery Disease
Clinical trial register · China

Coronary Artery Disease Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xi'an 6
Narrow the registerReset
Recruitment status
Phase
Site location
Xi'an6
All 1 locations
Target enrolment
to

Coronary Artery Disease trials in China

6 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Bioresorbable Sirolimus-eluting sca๏ฌ€old in de Novo Coronary Artery Lesions
NCT07022587De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,000
Xi'an
2025-12-20
Recruiting
Comparing the Components of Composite Endpoints for Healthcare Providers and Patients
NCT07378137Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
NCT07378163Coronary Artery Disease, Percutaneous Coronary Intervention
Xijing Hospital
Observational
600
Xi'an
2025-08-18
Recruiting
Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
NCT06572267Coronary Artery Disease
Xijing Hospital
Phase 2
18
Xi'an
2024-10-16
Recruiting
Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
NCT07180368Coronary Artery Disease, Diabete Mellitus, Chronic Kidney Disease, Hypertension
Xijing Hospital
Observational
2,000
Xi'an
2024-10-01
Active, closed
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
NCT04561739De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,272
Xi'an
2021-02-01
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/condition/coronary-artery-disease

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies listing the condition Coronary Artery Disease that also match the filters currently applied.

How many Coronary Artery Disease trials are recruiting in China?

5 of the 6 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Coronary Artery Disease), 6 studies
PhaseStudiesRecruitingShare
Observational3350%
Not applicable2133.3%
Phase 21116.7%

Most active sponsors

Lead sponsors with the most studies (Coronary Artery Disease)
Lead sponsorStudiesRecruiting
Xijing Hospital65
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.